Crossmark

Preliminary study on cytotoxicity of selegiline on different cancer cell lines: exploration of the induction of ROS-independent apoptosis in breast cancer cells

Crossref DOI link: https://doi.org/10.1007/s12032-024-02451-0

Published Online: 2024-07-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kumkar, Pratiksha Somnath

Chakraborty, Ratul

Upadhyay, Abhishek Motilal

Das, Jitu Mani

Bala, Asis https://orcid.org/0000-0002-2148-2331
Funding

Funding for this research was provided by:

Institute of Advanced Study in Science and Technology ((IASST/R&D/LCD/IHP-03/2024-25/693-700)
License Information

Text and Data Mining valid from 2024-07-20

Version of Record valid from 2024-07-20
More Information

Article History

Received: 6 June 2024

Accepted: 13 July 2024

First Online: 20 July 2024

Declarations

:

: The authors declare no competing interests.

: The experiments were conducted on commercially available human cell lines; therefore, no Institutional Animal Ethical Committee or Human Ethical Committee permission was required.

Document is current

Any future updates will be listed below